These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9167178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
    Greco IM, Calvisi G, Ventura L, Cerrito F.
    Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
    [Abstract] [Full Text] [Related]

  • 5. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B, Bodey B, Gröger AM, Siegel SE, Kaiser HE.
    Anticancer Res; 1997 Jun; 17(1A):505-11. PubMed ID: 9066703
    [Abstract] [Full Text] [Related]

  • 6. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
    Kanitakis J, Euvrard S, Bourchany D, Faure M, Claudy A.
    J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S, Oskarsson M, Spângberg B.
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [Abstract] [Full Text] [Related]

  • 8. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
    Saitoh K, Takahashi H, Yamamoto M, Kishi H, Parsons PG.
    Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi.
    Lee CS, Pirdas A, Lee MW.
    Pathology; 1996 Aug; 28(3):220-4. PubMed ID: 8912348
    [Abstract] [Full Text] [Related]

  • 10. The value of Nm23 expression as an independent prognostic indicator in primary thick melanoma.
    Holmes SC, MacKie RM.
    J Cutan Pathol; 1996 Aug; 23(4):344-9. PubMed ID: 8864922
    [Abstract] [Full Text] [Related]

  • 11. Expression of NM23 in human melanoma progression and metastasis.
    Easty DJ, Maung K, Lascu I, Véron M, Fallowfield ME, Hart IR, Bennett DC.
    Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up.
    Pacifico MD, Grover R, Richman PI, Buffa F, Daley FM, Wilson GD.
    Melanoma Res; 2005 Oct; 15(5):435-40. PubMed ID: 16179871
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome.
    McDermott NC, Milburn C, Curran B, Kay EW, Barry Walsh C, Leader MB.
    J Pathol; 2000 Feb; 190(2):157-62. PubMed ID: 10657013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma.
    Sarris M, Scolyer RA, Konopka M, Thompson JF, Harper CG, Lee CS.
    Melanoma Res; 2004 Feb; 14(1):23-7. PubMed ID: 15091190
    [Abstract] [Full Text] [Related]

  • 18. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
    Ferrari D, Lombardi M, Ricci R, Michiara M, Santini M, De Panfilis G.
    J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C, Obiols G, Castellví J, Tallada N, Galofré P, Gemar E, Mesa J, Simó R.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.